What Researchers Did
Researchers evaluated the effectiveness of hyperbaric oxygen therapy (HBOT) in 10 patients experiencing hemorrhagic cystitis and recurrent hematuria after pelvic radiotherapy for cancer.
What They Found
Total or partial resolution of hemorrhagic cystitis was observed in 6 out of 10 patients (60%) who received HBOT. Treatment was ineffective in 3 patients, and discontinued in 1 patient due to increased hematuria.
What This Means for Canadian Patients
For Canadian patients suffering from persistent hemorrhagic cystitis and hematuria following pelvic radiotherapy, HBOT may offer a potential treatment option. This therapy could help alleviate symptoms and improve quality of life for some individuals when other treatments have failed.
Canadian Relevance
This study was not conducted in Canada and does not have a direct Canadian connection.
Study Limitations
A significant limitation of this study is its very small sample size of only 10 patients, which limits the generalizability of the findings.